These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18725593)

  • 1. The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.
    Diederich NJ; Goetz CG
    Neurology; 2008 Aug; 71(9):677-84. PubMed ID: 18725593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of expectation on placebo-induced dopamine release in Parkinson disease.
    Lidstone SC; Schulzer M; Dinelle K; Mak E; Sossi V; Ruth TJ; de la Fuente-Fernández R; Phillips AG; Stoessl AJ
    Arch Gen Psychiatry; 2010 Aug; 67(8):857-65. PubMed ID: 20679593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo mechanisms and reward circuitry: clues from Parkinson's disease.
    de la Fuente-Fernández R; Schulzer M; Stoessl AJ
    Biol Psychiatry; 2004 Jul; 56(2):67-71. PubMed ID: 15231437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The placebo-reward hypothesis: dopamine and the placebo effect.
    de la Fuente-Fernández R
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S72-4. PubMed ID: 20083013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The placebo response: neurobiological and clinical issues of neurological relevance.
    Pollo A; Benedetti F
    Prog Brain Res; 2009; 175():283-94. PubMed ID: 19660663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Placebo effect in Parkinson's disease].
    Miwa H
    No To Shinkei; 2007 Feb; 59(2):139-46. PubMed ID: 17315755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemical bases for reward. Implications for the placebo effect.
    De La Fuente-Fernández R; Stoessl AJ
    Eval Health Prof; 2002 Dec; 25(4):387-98. PubMed ID: 12449082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging study of placebo analgesia in humans.
    Qiu YH; Wu XY; Xu H; Sackett D
    Neurosci Bull; 2009 Oct; 25(5):277-82. PubMed ID: 19784082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiological mechanisms of placebo responses.
    Zubieta JK; Stohler CS
    Ann N Y Acad Sci; 2009 Mar; 1156():198-210. PubMed ID: 19338509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of the placebo effect and of conditioning.
    Haour F
    Neuroimmunomodulation; 2005; 12(4):195-200. PubMed ID: 15990450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Placebo effect in Parkinson's disease].
    Miwa H
    Brain Nerve; 2007 Feb; 59(2):139-46. PubMed ID: 17380778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
    Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
    Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prefrontal non-opioid mechanism in placebo analgesia.
    Petrovic P; Kalso E; Petersson KM; Andersson J; Fransson P; Ingvar M
    Pain; 2010 Jul; 150(1):59-65. PubMed ID: 20399560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
    de la Fuente-Fernández R; Ruth TJ; Sossi V; Schulzer M; Calne DB; Stoessl AJ
    Science; 2001 Aug; 293(5532):1164-6. PubMed ID: 11498597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo responses in Parkinson's disease.
    Lou JS
    Int Rev Neurobiol; 2020; 153():187-211. PubMed ID: 32563288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.
    Koerts J; Leenders KL; Koning M; Portman AT; van Beilen M
    Eur J Neurosci; 2007 May; 25(10):3132-6. PubMed ID: 17561826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo and opioid analgesia-- imaging a shared neuronal network.
    Petrovic P; Kalso E; Petersson KM; Ingvar M
    Science; 2002 Mar; 295(5560):1737-40. PubMed ID: 11834781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How placebos change the patient's brain.
    Benedetti F; Carlino E; Pollo A
    Neuropsychopharmacology; 2011 Jan; 36(1):339-54. PubMed ID: 20592717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.
    Quattrone A; Barbagallo G; Cerasa A; Stoessl AJ
    Mov Disord; 2018 Aug; 33(8):1213-1227. PubMed ID: 30230624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function.
    Haltia LT; Rinne JO; Helin S; Parkkola R; Någren K; Kaasinen V
    Synapse; 2008 Sep; 62(9):682-8. PubMed ID: 18566972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.